SCM
Sio Capital Management Portfolio holdings
AUM
$249M
This Quarter Return
+35.36%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$323M
AUM Growth
+$323M
(+15%)
Cap. Flow
-$43.7M
Cap. Flow
% of AUM
-13.51%
Top 10 Holdings %
Top 10 Hldgs %
39.14%
Holding
98
New
27
Increased
15
Reduced
28
Closed
21
Top Buys
| 1 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
$9.88M |
| 2 |
SPDR Gold Trust
GLD
|
$9.37M |
| 3 |
Cencora
COR
|
$8.53M |
| 4 |
RCM
R1 RCM Inc. Common Stock
RCM
|
$8.51M |
| 5 |
SOLY
Soliton, Inc.
SOLY
|
$7.98M |
Top Sells
| 1 |
Larimar Therapeutics
LRMR
|
$25.9M |
| 2 |
Amgen
AMGN
|
$21.5M |
| 3 |
Envista
NVST
|
$12.8M |
| 4 |
IMAB
I-MAB
IMAB
|
$10.6M |
| 5 |
MEI Pharma
MEIP
|
$10M |
Sector Composition
| 1 | Healthcare | 81.51% |
| 2 | Industrials | 2.63% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $20.3M | 5.92% | 1,135,863 +58,024 | +5% | +$1.04M |
|
|
2
SPDR Gold Trust
GLD
$107B
| $20.2M | 5.9% | 120,702 +56,000 | +87% | +$9.37M |
|
3
McKesson
MCK
$85.4B
| $14.9M | 4.36% | 97,285 -35,055 | -26% | -$5.38M |
|
4
Teva Pharmaceuticals
TEVA
$21.1B
| $11.9M | 3.46% | 962,796 +390,115 | +68% | +$4.81M |
|
|
GWPH
5
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $11.7M | 3.4% | 94,984 -73,060 | -43% | -$8.97M |
|
|
6
Cencora
COR
$56.5B
| $10.1M | 2.96% | 100,545 +84,617 | +531% | +$8.53M |
|
7
Molina Healthcare
MOH
$9.8B
| $10.1M | 2.95% | 56,807 +20,834 | +58% | +$3.71M |
|
|
HRC
8
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $9.88M | 2.88% | +90,000 | New | +$9.88M |
|
9
Merck
MRK
$210B
| $8.84M | 2.58% | 114,350 +21,267 | +23% | +$1.64M |
|
10
Mersana Therapeutics
MRSN
$36.5M
| $8.7M | 2.54% | 371,781 +205,531 | +124% | +$4.81M |
|
|
RCM
11
DELISTED
R1 RCM Inc. Common Stock
RCM
| $8.51M | 2.48% | +763,023 | New | +$8.51M |
|
12
Elevance Health
ELV
$71.8B
| $8.37M | 2.44% | 31,819 -26,050 | -45% | -$6.85M |
|
|
CBAY
13
DELISTED
Cymabay Therapeutics
CBAY
| $8.03M | 2.34% | 2,299,982 +2,167,508 | +1,636% | +$7.56M |
|
|
SOLY
14
DELISTED
Soliton, Inc.
SOLY
| $7.98M | 2.33% | +1,025,000 | New | +$7.98M |
|
15
HCA Healthcare
HCA
$94.5B
| $7.93M | 2.32% | 81,732 +3,800 | +5% | +$369K |
|
16
United Therapeutics
UTHR
$13.8B
| $7.89M | 2.3% | 65,210 -25,613 | -28% | -$3.1M |
|
17
Eli Lilly
LLY
$657B
| $7.54M | 2.2% | +45,901 | New | +$7.54M |
|
18
Cardinal Health
CAH
$35.5B
| $6.97M | 2.03% | +133,500 | New | +$6.97M |
|
|
BMY.RT
19
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $6.16M | 1.8% | 1,719,271 -527,629 | -23% | -$1.89M |
|
20
Orthofix Medical
OFIX
$592M
| $6.14M | 1.79% | +191,891 | New | +$6.14M |
|
|
ARNA
21
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $5.99M | 1.75% | 95,153 +10,000 | +12% | +$630K |
|
22
OraSure Technologies
OSUR
$242M
| $5.35M | 1.56% | +460,000 | New | +$5.35M |
|
|
WBA
23
DELISTED
Walgreens Boots Alliance
WBA
| $5.27M | 1.54% | +124,194 | New | +$5.27M |
|
24
Curis
CRIS
$20.9M
| $5.2M | 1.52% | +4,300,051 | New | +$5.2M |
|
25
Viking Therapeutics
VKTX
$3.04B
| $5.12M | 1.49% | 709,780 -42,461 | -6% | -$306K |
|